The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Understanding type 1 diabetes through genetics: advances and prospects
Abstract
Starting with early crucial discoveries of the role of the major histocompatibility complex, genetic studies have long had a role in understanding the biology of type 1 diabetes (T1D), which is one of the most heritable common diseases. Recent genome-wide association studies (GWASs) have given us a clearer picture of the allelic architecture of genetic susceptibility to T1D. Fine mapping and functional studies are gradually revealing the complex mechanisms whereby immune self-tolerance is lost, involving multiple aspects of adaptive immunity. The triggering of these events by dysregulation of the innate immune system has also been implicated by genetic evidence. Finally, genetic prediction of T1D risk is showing promise of use for preventive strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of the remaining loci, only those for the insulin VNTR, PTPN22, CTLA4, and IL2RA are associated with odds ratios greater than 1·1.75”
From Type 1 diabetes (2014) · cites this paper as [75]
Citations
Cites
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein
Anderson, M. S., Venanzi, E. S., Klein, L., Chen, Z.-B., Berzins, S., Turley, S., von Boehmer, H., Bronson, R., Dierich, A., Benoist, C., et al. (2002) · Science · doi:10.1126/science.1075958 · Cited by 2,582
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
Todd, J. A., Bell, J. I., & McDevitt, H. O. (1987) · Nature · doi:10.1038/329599a0 · Cited by 2,036
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
The Type 1 Diabetes Genetics Consortium, Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.381 · Cited by 1,746
Genome structural variation discovery and genotyping
Alkan, C., Coe, B. P., & Eichler, E. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2958 · Cited by 1,630
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes
Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J. P., Meloni, T., Lucarelli, P., Pellecchia, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1323 · Cited by 1,419
Flagged first, then by citations
Research works printed but not linked: 1
- Zouk, H., Marchand, L. & Polychronakos, C. Study of transcriptional effects in cis at the IFIH1 locus. PLoS ONE 5, e11564 (2010). · DOI
Cited by
Sorted by citations
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425
Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.16 · Cited by 1,475
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Pitfalls of predicting complex traits from SNPs
Wray, N. R., Yang, J., Hayes, B. J., Price, A. L., Goddard, M. E., & Visscher, P. M. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3457 · Cited by 690
Lazăr, V., Diţu, L.-M., Pîrcălăbioru, G. G., Gheorghe, I., Curuțiu, C., Holban, A. M., Picu, A. A., Petcu, L. M., & Chifiriuc, M. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01830 · Cited by 552
Genetic architecture: the shape of the genetic contribution to human traits and disease
Timpson, N. J., Greenwood, C. M. T., Soranzo, N., Lawson, D. J., & Richards, J. B. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.101 · Cited by 434
Genetics of Type 2 Diabetes—Pitfalls and Possibilities
Prasad, R., & Groop, L. (2015) · Genes · doi:10.3390/genes6010087 · Cited by 458
Generation of stem cell-derived β-cells from patients with type 1 diabetes
Millman, J. R., Xie, C., Dervort, A. V., Gürtler, M., Pagliuca, F. W., & Melton, D. A. (2016) · Nature Communications · doi:10.1038/ncomms11463 · Cited by 390
Bringing genome-wide association findings into clinical use
Manolio, T. A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3523 · Cited by 363
Genetics and Pathogenesis of Inflammatory Bowel Disease
Liu, T.-C., & Stappenbeck, T. S. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044152 · Cited by 289
Metabolomics of type 1 and type 2 diabetes
Arneth, B., Arneth, R., & Shams, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102467 · Cited by 262
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes
Valle, A., Giamporcaro, G. M., Scavini, M., Stabilini, A., Grogan, P., Bianconi, E., Sebastiani, G., Masini, M., Maugeri, N., Porretti, L., et al. (2013) · Diabetes · doi:10.2337/db12-1345 · Cited by 203
Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets
Lü, J., Liu, J., Li, L., Lan, Y., & Liang, Y. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1122 · Cited by 180
Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice
Tai, N., Peng, J., Liu, F., Gülden, E., Hu, Y., Zhang, X., Chen, L., Wong, F. S., & Li, W. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160526 · Cited by 167
New Insights Into Gestational Glucose Metabolism: Lessons Learned From 21st Century Approaches
Angueira, A. R., Ludvik, A. E., Reddy, T. E., Wicksteed, B. L., Lowe, W. L., & Layden, B. T. (2015) · Diabetes · doi:10.2337/db14-0877 · Cited by 165
DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology
Stefan, M., Zhang, W., Concepcion, E., Yi, Z., & Tomer, Y. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.10.001 · Cited by 150
Genetic and Epigenetic Factors in Etiology of Diabetes Mellitus Type 1
Stankov, K., Benc, D., & Drašković, D. (2013) · PEDIATRICS · doi:10.1542/peds.2013-1652 · Cited by 135
Metabolomics in diabetes research
Friedrich, N. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0120 · Cited by 138
Bergholdt, R., Brorsson, C., Palleja, A., Berchtold, L. A., Fløyel, T., Bang-Berthelsen, C. H., Frederiksen, K. S., Jensen, L. J., Størling, J., & Pociot, F. (2012) · Diabetes · doi:10.2337/db11-1263 · Cited by 125
Type 1 diabetes: A predictable disease
Simmons, K. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.380 · Cited by 129
Marroquí, L., Santín, I., dos Santos, R. S., Marselli, L., Marchetti, P., & Eizirik, D. L. (2014) · Diabetes · doi:10.2337/db13-1443 · Cited by 113
Xie, X., Wu, C., Hao, Y., Wang, T., Yang, Y., Cai, P., Zhang, Y., Huang, J., Deng, K., Yan, D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1301093 · Cited by 129
Salas‐Pérez, F., Ethel Codner, D., Valencia, E., Pizarro, C., Carrasco, E., & Pérez‐Bravo, F. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.276 · Cited by 104
Type 1 diabetes genome‐wide association studies: not to be lost in translation
Pociot, F. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.51 · Cited by 101
Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review
Watkins, R. A., Evans‐Molina, C., Blum, J. S., & DiMeglio, L. A. (2014) · Translational research · doi:10.1016/j.trsl.2014.02.004 · Cited by 87
Interleukin-15 in autoimmunity
Allard‐Chamard, H., Mishra, H. K., Nandi, M., Mayhue, M., Menéndez, A., Ilangumaran, S., & Ramanathan, S. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155258 · Cited by 84
Stem-cell based organ-on-a-chip models for diabetes research
Rogal, J., Zbinden, A., Schenke‐Layland, K., & Loskill, P. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.010 · Cited by 89
Tomer, Y., Dolan, L. M., Kahaly, G. J., Divers, J., D'Agostino, R. B., Imperatore, G., Dabelea, D., Marcovina, S. M., Black, M. H., Pihoker, C., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.03.006 · Cited by 80
Santín, I., Moore, F., Grieco, F. A., Marchetti, P., Brancolini, C., & Eizirik, D. L. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.158 · Cited by 80
Achenbach, P., Hummel, M., Thümer, L., Boerschmann, H., Höfelmann, D., & Ziegler, A. G. (2013) · Diabetologia · doi:10.1007/s00125-013-2896-y · Cited by 76
The role of PTPN22 in the pathogenesis of autoimmune diseases: A comprehensive review
Tizaoui, K., Terrazzino, S., Cargnin, S., Lee, K. H., Gauckler, P., Li, H. J., Shin, J. I., & Kronbichler, A. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.03.004 · Cited by 76
Zilbauer, M., Rayner, T. F., Clark, C., Coffey, A. J., Joyce, C. J., Palta, P., Palotie, A. V., Lyons, P., & Smith, K. G. C. (2013) · Blood · doi:10.1182/blood-2013-05-503201 · Cited by 71
Yuan, X.-B., Jiang, X., Zhang, M., Wang, L., Wu, J., Chen, H., Mao, J., Ye, W., & Song, Q. (2024) · The Plant Cell · doi:10.1093/plcell/koae062 · Cited by 70
12q24 locus association with type 1 diabetes:SH2B3orATXN2?
Auburger, G. W. J. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i3.316 · Cited by 64
Carbonetto, P. S., & Stephens, M. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003770 · Cited by 68
Functional profiling of the gut microbiome in disease-associated inflammation
Börnigen, D., Morgan, X. C., Franzosa, E. A., Ren, B., Xavier, R. J., Garrett, W. S., & Huttenhower, C. (2013) · Genome Medicine · doi:10.1186/gm469 · Cited by 72
Genetic heterogeneity: Challenges, impacts, and methods through an associative lens
Woodward, A., Urbanowicz, R. J., Naj, A. C., & Moore, J. H. (2022) · Genetic Epidemiology · doi:10.1002/gepi.22497 · Cited by 71
Antigen Presentation in the Autoimmune Diabetes of the NOD Mouse
Unanue, E. R. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095941 · Cited by 63
Wang, Q., Xi, B., Reilly, K. H., Liu, M., & Fu, M. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1805-7 · Cited by 63
MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research
Juan‐Mateu, J., Villate, O., & Eizirik, D. L. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0916 · Cited by 59
Anti-Inflammatory Therapy in Type 1 Diabetes
Baumann, B., Salem, H. H., & Boehm, B. O. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0299-y · Cited by 59
Genetic Epidemiology of Type 1 Diabetes in the 22 Arab Countries
Zayed, H. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0736-4 · Cited by 56
Qin, J., Fu, S., Speake, C., Greenbaum, C. J., & Odegard, J. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12783 · Cited by 55
Safari‐Alighiarloo, N., Taghizadeh, M. T., Tabatabaei, S. M., Shahsavari, S., Namaki, S., Khodakarim, S., & Rezaei–Tavirani, M. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12483 · Cited by 54
Gioia, L., Holt, M., Costanzo, A. E., Sharma, S. M., Abe, B. T., Kain, L., Nakayama, M., Wan, X., Su, A. I., Mathews, C. E., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aaw6329 · Cited by 54
Autoimmunity's next top models
Wekerle, H., Flügel, A., Fugger, L. H., Schett, G. A., & SERREZE, D. V. (2012) · Nature Medicine · doi:10.1038/nm.2635 · Cited by 53
Busch, R., Riva, A. D., Hadjinicolaou, A. V., Jiang, W., Hou, T., & Mellins, E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.9 · Cited by 53
Perry, J. S. A., & Hsieh, C. (2016) · Immunological Reviews · doi:10.1111/imr.12403 · Cited by 56
Pizarro, C., García‐Díaz, D. F., Ethel Codner, D., Salas‐Pérez, F., Carrasco, E., & Pérez‐Bravo, F. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2552 · Cited by 51
O’Kell, A. L., Wasserfall, C. H., Catchpole, B., Davison, L. J., Hess, R. S., Kushner, J. A., & Atkinson, M. A. (2017) · Diabetes · doi:10.2337/db16-1551 · Cited by 54
Dietary Cows’ Milk Protein A1 Beta-Casein Increases the Incidence of T1D in NOD Mice
Chia, J. S., McRae, J. L., Enjapoori, A. K., Lefèvre, C. M., Kukuljan, S., & Dwyer, K. M. (2018) · Nutrients · doi:10.3390/nu10091291 · Cited by 52
New Opportunities: Harnessing Induced Pluripotency for Discovery in Diabetes and Metabolism
Teo, A. K. K., Wagers, A. J., & Kulkarni, R. N. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.010 · Cited by 49
Monogenic autoimmune diseases of the endocrine system
Johnson, M. B., Hattersley, A. T., & Flanagan, S. E. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30095-x · Cited by 48
Yang, L., Chen, S., Zhao, Q., Sun, Y., & Nie, H. (2019) · Mediators of Inflammation · doi:10.1155/2019/2609737 · Cited by 47
The NOD Mouse Beyond Autoimmune Diabetes
Aubin, A., Lombard‐Vadnais, F., Collin, R., Aliesky, H. A., McLachlan, S. M., & Lesage, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.874769 · Cited by 51
The multi-faceted functioning portrait of LRF/ZBTB7A
Constantinou, C., Σπέλλα, Μ., Chondrou, V., Patrinos, G. P., Papachatzopoulou, A., & Sgourou, A. (2019) · Human Genomics · doi:10.1186/s40246-019-0252-0 · Cited by 48
Genetic Aspects of type 1 diabetes
Lee, H. S., & Hwang, J. S. (2019) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2019.24.3.143 · Cited by 57
Boîtard, C. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.10.003 · Cited by 48
Loh, N. Y., Bentley, L., Dimke, H., Verkaart, S., Tammaro, P., Gorvin, C. M., Stechman, M., Ahmad, B. N., Hannan, F. M., Piret, S. E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055412 · Cited by 43
Advances in immunotherapy of type I diabetes
Ni, Q., Pham, N. B., Meng, W. S., Zhu, G., & Chen, X. S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.003 · Cited by 42
Natural Killer Cells as Key Mediators in Type I Diabetes Immunopathology
Gardner, G., & Fraker, C. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722979 · Cited by 44
Bakker, S. F., Tushuizen, M. E., Stokvis‐Brantsma, W. H., Aanstoot, H., Winterdijk, P., van Setten, P. A., Flier, B., Mulder, C. J. J., & Şimşek, S. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2013.01.016 · Cited by 41
Genome-Wide Scan Reveals LEMD3 and WIF1 on SSC5 as the Candidates for Porcine Ear Size
Zhang, L., Liang, J., Luo, W., Liu, X., Yan, H., Zhao, K., Shi, H., Zhang, Y., Wang, L., & Wang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102085 · Cited by 40
O’Brien, R. M. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0422-8 · Cited by 40
Modeling different types of diabetes using human pluripotent stem cells
Abdelalim, E. M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03710-9 · Cited by 38
Helminth Infection and Type 1 Diabetes
Zaccone, P., & Hall, S. W. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.272 · Cited by 43
The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors
Cangoz, S., Chang, Y.-Y., Chempakaseril, S. J., Guduru, R. C., Huynh, L. M., John, J. S., John, S. T., Joseph, M. E., Judge, R., Kimmey, R., et al. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12077 · Cited by 35
Association of 32 type 1 diabetes risk loci in Pakistani patients
Kiani, A. K., John, P. C. L., Bhatti, A., Zia, A., Shahid, G., Akhtar, P., Wang, X., Demirci, F. Y., & Kamboh, M. I. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.022 · Cited by 35
Type 1 diabetes: genes associated with disease development
Klak, M., Gomółka, M., Kowalska, P. D., Cichoń-Woźniak, J., Ambrożkiewicz, F., Serwańska-Świętek, M., Berman, A., & Wszola, M. (2021) · Central European Journal of Immunology · doi:10.5114/ceji.2020.103386 · Cited by 39
Wong, A. S. L., Mortin-Toth, S. M., Sung, M., Canty, A. J., Gulban, O., Greaves, D. R., & Danska, J. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401984 · Cited by 34
Tsukumo, S., Subramani, P. G., Seija, N., Tabata, M., Maekawa, Y., Mori, Y., Ishifune, C., Itoh, Y., Ota, M., Fujio, K., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq0008 · Cited by 36
Identification of loci where DNA methylation potentially mediates genetic risk of type 1 diabetes
Ye, Y., Richardson, T. G., McArdle, W. L., Relton, C. L., Gillespie, K. M., Suderman, M. J., & Hemani, G. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.06.005 · Cited by 33
Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis
Leung, S. S., Forbes, J. M., & Borg, D. J. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0782-y · Cited by 31
A Critical Role for the Type I Interferon Receptor in Virus-Induced Autoimmune Diabetes in Rats
Qaisar, N., Lin, S., Ryan, G., Yang, C., Oikemus, S., Brodsky, M. H., Bortell, R., Mordes, J. P., & Wang, J. P. (2016) · Diabetes · doi:10.2337/db16-0462 · Cited by 31
Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence
Huang, Q., & Zhu, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112724 · Cited by 33
Unravelling the Roles of Susceptibility Loci for Autoimmune Diseases in the Post-GWAS Era
Ye, Y., Gillespie, K. M., & Rodrı́guez, S. (2018) · Genes · doi:10.3390/genes9080377 · Cited by 31
Alnaqbi, H., Mawart, A., Alshamsi, J., AlSafar, H. S., & Tay, G. K. (2021) · Immunogenetics · doi:10.1007/s00251-021-01204-x · Cited by 31
Environmental factors in the etiology of type 1 diabetes, celiac disease, and narcolepsy
Lernmark, Å. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12390 · Cited by 29
Cho, Y., Latour, L. L., Kim, H., Turtzo, L. C., Olivera, A., Livingston, W. S., Wang, D., Martin, C. G., Lai, C., Cashion, A. K., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00168 · Cited by 27
Increased expression of microRNAs, miR-20a and miR-326 in PBMCs of patients with type 1 diabetes
Azhir, Z., Dehghanian, F., & Hojati, Z. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4352-z · Cited by 27
Progress in Understanding Type 1 Diabetes Through Its Genetic Overlap with Other Autoimmune Diseases
Roizen, J. D., Bradfield, J. P., & Hakonarson, H. H. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0668-4 · Cited by 27
Teo, A. K. K., Gupta, M. K., Doria, A., & Kulkarni, R. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.06.006 · Cited by 26
Aydemir, Ö., Noble, J. A., Bailey, J. A., Lernmark, Å., Marsh, P. W., Svärd, A. A., Bearoff, F. M., Blankenhorn, E. P., Mordes, J. P., Better Diabetes Diagnosis (BDD) Study Group, et al. (2019) · Diabetes · doi:10.2337/db18-1128 · Cited by 25
New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes
Cabello-Olmo, M., Araña, M., Radichev, I., Smith, P., Huarte, E., & Barajas, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194789 · Cited by 28
Candidate Genes Expressed in Human Islets and Their Role in the Pathogenesis of Type 1 Diabetes
Størling, J., & Brorsson, C. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0408-6 · Cited by 26
Marwaha, A., Panagiotopoulos, C., Biggs, C. M., Staiger, S., Bel, K. L. D., Hirschfeld, A. F., Priatel, J. J., Turvey, S. E., & Tan, R. (2017) · Genes and Immunity · doi:10.1038/gene.2016.44 · Cited by 25
The β-Cell Genomic Landscape in T1D: Implications for Disease Pathogenesis
Ramos-Rodríguez, M., Pérez-González, B., & Pasquali, L. (2021) · Current Diabetes Reports · doi:10.1007/s11892-020-01370-4 · Cited by 26
Reversal of New-Onset Type 1 Diabetes With an Agonistic TLR4/MD-2 Monoclonal Antibody
Bednar, K. J., Tsukamoto, H., Kachapati, K., Ohta, S., Wu, Y., Katz, J. D., Ascherman, D. P., & Ridgway, W. M. (2015) · Diabetes · doi:10.2337/db14-1868 · Cited by 25
Allelic Variation, Aneuploidy, and Nongenetic Mechanisms Suppress a Monogenic Trait in Yeast
Sirr, A., Cromie, G. A., Jeffery, E. W., Gilbert, T., Ludlow, C. L., Scott, A. C., & Dudley, A. M. (2014) · Genetics · doi:10.1534/genetics.114.170563 · Cited by 26
Sumoylation Modulates the Susceptibility to Type 1 Diabetes
Zhang, J., Chen, Z., Zhou, Z., Yang, P. C., & Wang, C. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_18 · Cited by 24
Lo, B., Swafford, A. D.-E., Shafer-Weaver, K., Jerome, L. F., Rakhlin, L., Mathern, D. R., Callahan, C. A., Jiang, P. D., Davison, L. J., Stevens, H. E., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-203 · Cited by 26
Genetic architecture of human fibrotic diseases: disease risk and disease progression
Gardet, A., Zheng, T. S., & Viney, J. L. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00159 · Cited by 23
Autologous Regulatory T Cells for the Treatment of Type 1 Diabetes
Thompson, J. A., Perry, D. J., & Brusko, T. M. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0304-5 · Cited by 21
Krupa‐Kozak, U., & Lange, E. (2019) · Food Reviews International · doi:10.1080/87559129.2019.1584902 · Cited by 22
Analysis of potential hub genes involved in the pathogenesis of Chinese type 1 diabetic patients
Yang, S., Cao, C., Xie, Z., & Zhou, Z. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.171 · Cited by 21
Diabetes and Tryptophan Metabolism
Ünlütürk, U., & Erbas, T. A. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15630-9_7 · Cited by 20
Genomics and personalised whole-of-life healthcare
Bauer, D. C., Gaff, C., Dinger, M. E., Caramins, M. C., Buske, F. A., Fenech, M. F., Hansen, D. T., & Cobiac, L. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.04.001 · Cited by 20
Bakker, S. F., Tushuizen, M. E., Flier, B., Bontkes, H. J., Mulder, C. J. J., & Şimşek, S. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0166-0 · Cited by 20
A low-frequency GLIS3 variant associated with resistance to Japanese type 1 diabetes
Awata, T., Yamashita, H., Kurihara, S., Morita‐Ohkubo, T., Miyashita, Y., Katayama, S., Kawasaki, E., Tanaka, S. A., Ikegami, H., Maruyama, T., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.102 · Cited by 19
Metadata
- Authors
- Polychronakos, C., & Li, Q.
- Affiliations
- McGill University (CA)
- Corresponding author
- Polychronakos, Constantin
- Venue
- Nature Reviews Genetics
- Published
- 2011-10-18
- Volume
- 12
- Issue
- 11
- Pages
- 781-792
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W2166110465
- Cited by
- 226
- References
- 98
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 10 · 2023: 12 · 2022: 11 · 2021: 16 · 2020: 12 · 2019: 12 · 2018: 11 · 2017: 17 · 2016: 23 · 2015: 17 · 2014: 18 · 2013: 32 · 2012: 26
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, genetic susceptibility, genetic susceptibility loci, major histocompatibility complex, self-tolerance, adaptive immunity, innate immune dysregulation, fine mapping, genetic risk prediction, disease prevention
- MeSH terms
- Alleles, Animals, Diabetes Mellitus, Type 1, Disease Models, Animal, Humans, Immune Tolerance, Immunity, Innate, Major Histocompatibility Complex, Genetic Predisposition to Disease, Quantitative Trait Loci, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review